Regeneron Pharmaceuticals (REGN) Non Operating Income (2009 - 2026)
Regeneron Pharmaceuticals' quarterly Non Operating Income came in at $201.2 million in Q1 2026, down 37.52% year-on-year from $322.0 million in Q1 2025, and up 14.32% quarter-over-quarter from $176.0 million in Q4 2025.
Regeneron Pharmaceuticals has reported Non Operating Income for 18 years, with the latest figure at $201.2 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 37.52% year-over-year to $201.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 billion (up 39.0% YoY), and the FY2025 full-year result was $1.7 billion, up 114.98% from the prior year.
- Non Operating Income for Q1 2026 stood at $201.2 million, up from $176.0 million in the prior quarter.
- The five-year high for Non Operating Income was $736.5 million in Q3 2025, with the low at -$197.4 million in Q1 2022.
- Average Non Operating Income over 5 years is $172.4 million, with a median of $176.0 million recorded in 2025.
- Year-over-year, Non Operating Income sank 227.44% in 2022 and surged 156850.0% in 2024.
- Tracing REGN's Non Operating Income over 5 years: stood at $237.3 million in 2022, then plunged by 49.43% to $120.0 million in 2023, then plunged by 164.0% to -$76.8 million in 2024, then jumped by 329.17% to $176.0 million in 2025, then grew by 14.32% to $201.2 million in 2026.
- The last three Non Operating Income figures came in at $201.2 million (Q1 2026), $176.0 million (Q4 2025), and $736.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 444,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 201.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -46.98 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -8.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 201.20 Mn |
| Dec 31, 2025 | 176.00 Mn |
| Sep 30, 2025 | 736.50 Mn |
| Jun 30, 2025 | 439.20 Mn |
| Mar 31, 2025 | 322.00 Mn |
| Dec 31, 2024 | -76.80 Mn |
| Sep 30, 2024 | 313.50 Mn |
| Jun 30, 2024 | 558.50 Mn |
| Mar 31, 2024 | -34.60 Mn |
| Dec 31, 2023 | 120.00 Mn |
| Sep 30, 2023 | -200,000.00 |
| Jun 30, 2023 | 66.40 Mn |
| Mar 31, 2023 | -70.70 Mn |
| Dec 31, 2022 | 237.30 Mn |
| Sep 30, 2022 | 286.10 Mn |
| Jun 30, 2022 | -146.70 Mn |
| Mar 31, 2022 | -197.40 Mn |
| Dec 31, 2021 | -136.30 Mn |
| Sep 30, 2021 | -30.60 Mn |
| Jun 30, 2021 | 405.60 Mn |
| Mar 31, 2021 | 154.90 Mn |
| Dec 31, 2020 | 114.50 Mn |
| Sep 30, 2020 | -54.80 Mn |
| Jun 30, 2020 | 272.20 Mn |
| Mar 31, 2020 | -25.40 Mn |
| Dec 31, 2019 | 220.80 Mn |
| Sep 30, 2019 | 53.50 Mn |
| Jun 30, 2019 | -90.90 Mn |
| Mar 31, 2019 | 66.10 Mn |
| Dec 31, 2018 | -13.70 Mn |
| Sep 30, 2018 | 9.00 Mn |
| Jun 30, 2018 | 40.80 Mn |
| Mar 31, 2018 | 24.60 Mn |
| Dec 31, 2017 | -3.15 Mn |
| Sep 30, 2017 | 5.68 Mn |
| Jun 30, 2017 | -19.06 Mn |
| Mar 31, 2017 | 1.75 Mn |
| Dec 31, 2016 | -5.45 Mn |
| Sep 30, 2016 | 3.58 Mn |
| Jun 30, 2016 | 628,000.00 |
| Mar 31, 2016 | 3.48 Mn |
| Dec 31, 2015 | 10.45 Mn |
| Sep 30, 2015 | 867,000.00 |
| Jun 30, 2015 | 18.52 Mn |
| Mar 31, 2015 | 7.21 Mn |
| Dec 31, 2014 | -26.08 Mn |
| Sep 30, 2014 | -6.64 Mn |
| Jun 30, 2014 | -19.29 Mn |
| Mar 31, 2014 | -10.68 Mn |
| Dec 31, 2013 | -13.92 Mn |
| Sep 30, 2013 | -11.12 Mn |
| Jun 30, 2013 | -10.41 Mn |
| Mar 31, 2013 | -11.22 Mn |
| Dec 31, 2012 | -11.11 Mn |
| Sep 30, 2012 | -10.90 Mn |
| Jun 30, 2012 | -10.74 Mn |
| Mar 31, 2012 | -10.55 Mn |
| Dec 31, 2011 | -8.66 Mn |
| Sep 30, 2011 | -3.35 Mn |
| Jun 30, 2011 | -3.05 Mn |
| Mar 31, 2011 | -2.68 Mn |
| Dec 31, 2010 | -1.82 Mn |
| Sep 30, 2010 | -1.78 Mn |
| Jun 30, 2010 | -1.75 Mn |
| Mar 31, 2010 | -1.65 Mn |
| Dec 31, 2009 | -1.20 Mn |
| Sep 30, 2009 | 276,000.00 |
| Jun 30, 2009 | 1.33 Mn |